| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 6.874 | 363 |
| Total Expenses - EUR | - | - | 0 | 1.387 | 1.899 | 657 | 770 | 3.123 | 7.591 | 867 |
| Gross Profit/Loss - EUR | - | - | 0 | -1.387 | -1.899 | -657 | -770 | -3.123 | -718 | -504 |
| Net Profit/Loss - EUR | - | - | 0 | -1.387 | -1.899 | -657 | -770 | -3.123 | -718 | -504 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medicorp Global Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 12.733 | 12.486 | 12.249 | 11.978 | 19.760 | 13.006 | 12.933 |
| Current Assets | - | - | 35 | 81 | 25 | 50 | 448 | 208 | 3.740 | 3.678 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 448 | 0 | 3.715 | 3.695 |
| Cash | - | - | 35 | 81 | 25 | 50 | 0 | 208 | 25 | -17 |
| Shareholders Funds | - | - | 44 | -1.344 | -3.217 | -3.812 | -4.498 | -7.636 | -8.330 | -8.788 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 339 | 14.638 | 16.261 | 16.658 | 17.395 | 27.604 | 25.077 | 25.399 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medicorp Global Srl